Trials that use: P-values
New to this method? Read the tutorial →
20,601 results
- Patient Perception Questionnaire Validation: Complete Statistical AnalysisIndependent statistical analysis of Patient Perception Questionnaire Validation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02067000).
- Patient Portal Flu Vaccine Reminders (5): Complete Statistical AnalysisIndependent statistical analysis of Patient Portal Flu Vaccine Reminders (5): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05525494).
- Patient Preference Comparison of AZARGA Versus COSOPT: Complete Statistical AnalysisIndependent statistical analysis of Patient Preference Comparison of AZARGA Versus COSOPT: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01340014).
- Patient Reported Satisfaction With Contoura LASIK Utilizing the Phorcides Analytic Software: Complete Statistical AnalysisIndependent statistical analysis of Patient Reported Satisfaction With Contoura LASIK Utilizing the Phorcides Analytic Software: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Patient Satisfaction Study: Clean Intermittent Self-Catheterization Teaching: Complete Statistical AnalysisIndependent statistical analysis of Patient Satisfaction Study: Clean Intermittent Self-Catheterization Teaching: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00678444).
- Patient-Directed Antimicrobial Duration in Acute Uncomplicated Pyelonephritis: Complete Statistical AnalysisIndependent statistical analysis of Patient-Directed Antimicrobial Duration in Acute Uncomplicated Pyelonephritis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT06127160).
- Patient-Reported Outcomes Measurement Information System Integration Into Rheumatology Clinical Practice: Complete Statistical AnalysisIndependent statistical analysis of Patient-Reported Outcomes Measurement Information System Integration Into Rheumatology Clinical Practice: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05026853).
- Patients Receiving Induction With Liposomal Daunorubicin and Cytarabine (CPX-351) for Acute Myeloid Leukemia: Complete Statistical AnalysisIndependent statistical analysis of Patients Receiving Induction With Liposomal Daunorubicin and Cytarabine (CPX-351) for Acute Myeloid Leukemia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Patients With Geographic Atrophy and Their Patient Journey in the United States (US): Complete Statistical AnalysisIndependent statistical analysis of Patients With Geographic Atrophy and Their Patient Journey in the United States (US): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Patients With Metastatic Colorectal Cancer Treated With Regorafenib or Placebo After Failure of Standard Therapy: Complete Statistical AnalysisIndependent statistical analysis of Patients With Metastatic Colorectal Cancer Treated With Regorafenib or Placebo After Failure of Standard Therapy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- PATINAIndependent statistical analysis of Randomized, Open Label, Clinical Study of the Targeted Therapy, Palbociclib, to Treat Metastatic Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- PATTErnIndependent statistical analysis of A Study of Physical Activity paTTerns and Major Health Events in Older People With Implantable Cardiac Devices: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- PAUSEIndependent statistical analysis of Efficacy of Ustekinumab Followed by Abatacept for the Treatment of Psoriasis Vulgaris: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Paxerol™ for Treatment of Nocturia – A Phase II Placebo-Controlled Trial: Complete Statistical AnalysisIndependent statistical analysis of Paxerol™ for Treatment of Nocturia - A Phase II Placebo-Controlled Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Pay-it-forward RCT for Gonorrhea and Chlamydia Testing: Complete Statistical AnalysisIndependent statistical analysis of Pay-it-forward RCT for Gonorrhea and Chlamydia Testing: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03741725).
- Pazopanib as Front-Line Therapy in Patients With Non-Resectable or Metastatic Soft Tissue Sarcomas Who Are Not Candidates for Chemotherapy: Complete Statistical AnalysisIndependent statistical analysis of Pazopanib as Front-Line Therapy in Patients With Non-Resectable or Metastatic Soft Tissue Sarcomas Who Are Not Candidates for Chemotherapy: primary endpoint results, effect estimate with confidence interval, sample-size…
- Pazopanib As Pre-Surgical Therapy In Treatment-Naive Subjects With Non-Small Cell Lung Cancer: Complete Statistical AnalysisIndependent statistical analysis of Pazopanib As Pre-Surgical Therapy In Treatment-Naive Subjects With Non-Small Cell Lung Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Pazopanib Hydrochloride in Treating Patients With Advanced Thyroid Cancer: Complete Statistical AnalysisIndependent statistical analysis of Pazopanib Hydrochloride in Treating Patients With Advanced Thyroid Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00625846).
- Pazopanib Hydrochloride in Treating Patients With Stage IV or Recurrent Nasopharyngeal Cancer: Complete Statistical AnalysisIndependent statistical analysis of Pazopanib Hydrochloride in Treating Patients With Stage IV or Recurrent Nasopharyngeal Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Pazopanib in Patients With Relapsed or Refractory Small Cell Lung Cancer: Complete Statistical AnalysisIndependent statistical analysis of Pazopanib in Patients With Relapsed or Refractory Small Cell Lung Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Pazopanib in Treating Patients With Metastatic Urothelial Cancer: Complete Statistical AnalysisIndependent statistical analysis of Pazopanib in Treating Patients With Metastatic Urothelial Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00471536).
- Pazopanib Plus Lapatinib Compared To Lapatinib Alone In Subjects With Advanced Or Metastatic Breast Cancer: Complete Statistical AnalysisIndependent statistical analysis of Pazopanib Plus Lapatinib Compared To Lapatinib Alone In Subjects With Advanced Or Metastatic Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Pazopanib Versus Temsirolimus in Poor-Risk Clear-Cell Renal Cell Carcinoma (RCC): Complete Statistical AnalysisIndependent statistical analysis of Pazopanib Versus Temsirolimus in Poor-Risk Clear-Cell Renal Cell Carcinoma (RCC): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01392183).
- PazufloxacinIndependent statistical analysis of Safety and Efficacy of PRO-157 vs Moxifloxacin vs Gatifloxacin in Patients With Bacterial Conjunctivitis (Pazufloxacin): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- PBAMD2Independent statistical analysis of ProspectiveTrial of Proton Beam Combined With Anti-VEGF Therapy for Exudative Age-related Macular Degeneration (AMD): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- PBFR2Independent statistical analysis of Assessment of Efficacy of Low Intensity Resistance Training in Women at Risk for Symptomatic Knee Osteoarthritis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- PBroCIndependent statistical analysis of Chemoprevention of Prostate Cancer, HDAC Inhibition and DNA Methylation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01265953).
- PBSWIndependent statistical analysis of Evaluation of an Algorithm to Detect Sleep and Wake in Continuous Positive Airway Pressure (CPAP): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- PbVacIndependent statistical analysis of Safety and Protective Efficacy of Pb(PfCS@UIS4): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03138096).
- PCC vs. FFP for Post Cardiopulmonary Bypass Coagulopathy and Bleeding: Complete Statistical AnalysisIndependent statistical analysis of PCC vs. FFP for Post Cardiopulmonary Bypass Coagulopathy and Bleeding: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02557672).
- PCIIndependent statistical analysis of A Clinical Trial to Demonstrate the Efficacy of Cangrelor: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00305162).
- PCMH-KDIndependent statistical analysis of Bringing Care to Patients: Patient-Centered Medical Home for Kidney Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02270515).
- PCN1Independent statistical analysis of Patient Centered-Rehabilitation ver111090.1: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03034954).
- PCORIIndependent statistical analysis of Ostomy Telehealth For Cancer Survivors: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02974634).
- PCORI OHIndependent statistical analysis of Optimizing Behavioral Health Homes for Adults With Serious Mental Illness: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02318797).
- PCORI Urea Cycle Disorder Study: Complete Statistical AnalysisIndependent statistical analysis of PCORI Urea Cycle Disorder Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02740153).
- PCOSIndependent statistical analysis of Effects of Pioglitazone on Insulin and Glucose Metabolism in Women With Polycystic Ovary Syndrome (PCOS): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- PCOSIndependent statistical analysis of Efficacy Study of Raloxifene to Induce Ovulation in Polycystic Ovarian Syndrome: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- PCR PS TKAIndependent statistical analysis of Knee Kinematics for Subjects With Zimmer-Biomet Posterior Cruciate Retaining or Posterior Stabilizing Total Knee Arthroplasty: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- PCR-MIBIndependent statistical analysis of Pembrolizumab With Chemoradiotherapy as Treatment for Muscle Invasive Bladder Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02662062).
- PCSK9 Inhibitor and PD-1 Inhibitor in Patients With Metastatic, Refractory To Prior Anti PD-1 Non-small Cell Lung: Complete Statistical AnalysisIndependent statistical analysis of PCSK9 Inhibitor and PD-1 Inhibitor in Patients With Metastatic, Refractory To Prior Anti PD-1 Non-small Cell Lung: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- PCTDMRTTIndependent statistical analysis of Placebo Controlled Trial of Dextromethorphan in Rett Syndrome: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01520363).
- PCV13 Effectiveness Study Against Hospitalised VT Pneumococcal CAP in Adults 60 Years and Older: Complete Statistical AnalysisIndependent statistical analysis of PCV13 Effectiveness Study Against Hospitalised VT Pneumococcal CAP in Adults 60 Years and Older: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- PDIndependent statistical analysis of Vancomycin Plus Moxifloxacin Versus Vancomycin Plus Ceftazidime for the Treatment of Peritoneal Dialysis (PD)-Related Peritonitis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- PDIndependent statistical analysis of Randomized, Double-Blind Clinical Trial for Parkinson's Disease (Early and Moderate): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04928287).
- PD and Safety of TG-0054 Combined With G-CSF in Multiple Myeloma, Non-Hodgkin Lymphoma and Hodgkin Disease Patients: Complete Statistical AnalysisIndependent statistical analysis of PD and Safety of TG-0054 Combined With G-CSF in Multiple Myeloma, Non-Hodgkin Lymphoma and Hodgkin Disease Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- PD-1 Inhibition to Determine CNS Reservoir of HIV-Infection: Complete Statistical AnalysisIndependent statistical analysis of PD-1 Inhibition to Determine CNS Reservoir of HIV-Infection: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03239899).
- PD0332991Independent statistical analysis of A Study of PD 0332991 in Patients With Recurrent Rb Positive Glioblastoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- PD0332991 (Palbociclib) in Patients With Advanced or Metastatic Liposarcoma: Complete Statistical AnalysisIndependent statistical analysis of PD0332991 (Palbociclib) in Patients With Advanced or Metastatic Liposarcoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01209598).
- PDA+Independent statistical analysis of PDA+: A Personal Digital Assistant for Obesity Treatment: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00371462).